EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Injectable ε-Polylysine/Hyaluronic Acid Hydrogels with Resistance-Preventing Antibacterial Activity for Treating Wound Infections

Artemijs Sceglovs, Claudia Siverino, Ingus Skadins, Marika Sceglova, Valdis Pirsko, Thomas Fintan Moriarty iD, Juta Kroica, Kristine Salma-Ancane iD

ACS Applied Bio Materials · 2025

DOI: 10.1021/acsabm.5c01252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2025. Verfasst von Artemijs Sceglovs und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomaterials and Bioengineering, Faculty of Natural Sciences and Technology, Riga Technical University, Paula Valdena St. 3, Riga lv-104…. Hauptthemen laut MEDLINE: Hyaluronic Acid, Hydrogels, Anti-Bacterial Agents, Polylysine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 Spreading Excellence and Widening Participation, Rigas Tehniska Universitate.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The growing threat of antimicrobial resistance has created an urgent demand for nonantibiotic biomaterials capable of preventing infections without promoting bacterial resistance. In this study, we developed injectable, covalently cross-linked hydrogels composed of ε-poly-l-lysine (ε-PL) and hyaluronic acid (HA) for localized wound infection treatment. These hydrogels combine the inherent antibacterial properties of ε-PL with the biocompatibility of HA, forming a shear-thinning, self-recovering system suitable for syringe-based administration. We first evaluated the antibacterial activity of pure ε-PL, determining minimum inhibitory and bactericidal concentrations (MIC/MBC) and evaluating resistance development against ATCC and clinically isolated multidrug-resistant strains (MRSA, ESBL-E. coli, P. aeruginosa). Notably, no resistance emerged in any strain after the serial passages. Hydrogels formed at varying ε-PL/HA ratios demonstrated strong immediate and long-term bactericidal activity while maintaining high cytocompatibility with murine and human fibroblasts. The hydrogels significantly reduced biofilm formation of S. aureus and MRSA within 24 h, achieving reductions comparable to or greater than vancomycin-gentamicin controls. Rheological analysis confirmed injectability, stability, and tunable stiffness. This study presents the first demonstration that ε-PL-based hydrogels can prevent resistance development in multidrug-resistant pathogens, offering a safe and antibiotic-free approach for infection control. The combination of antibacterial efficacy, resistance prevention, and biocompatibility makes these hydrogels promising candidates for wound infection management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronic AcidHydrogelsAnti-Bacterial AgentsPolylysineBiocompatible MaterialsWound InfectionMicrobial Sensitivity TestsHumansAnimalsMiceMaterials TestingMethicillin-Resistant Staphylococcus aureusPseudomonas aeruginosaBiofilmsEscherichia coliStaphylococcus aureusInjections

Stichwörter der Autor:innen

antibacterial hydrogelsantibiofilmhyaluronic acidmultidrug-resistant bacteriaresistance preventionε-polylysine

Substanzen

Hyaluronic AcidHydrogelsAnti-Bacterial AgentsPolylysineBiocompatible Materials

Autor:innen und Institutionen

  • Institute of Biomaterials and Bioengineering, Faculty of Natural Sciences and Technology, Riga Technical University, Paula Valdena St. 3, Riga lv-1048, Latvia.
  • Baltic Biomaterials Centre of Excellence, Headquarters at Riga Technical University, Paula Valdena St. 3, K-1, Riga lv-1048, Latvia.
  • AO Research Institute Davos, Clavadelerstrasse 8, Davos 7270, Switzerland.
  • Department of Biology and Microbiology, Riga Stradins University, Dzirciema St. 16 Riga lv-1007, Latvia.
  • Institute of Microbiology and Virology, Riga Stradins University, Ratsupites St. 5, Riga lv-1067, Latvia.

ORCID-Profile: Thomas Fintan Moriarty, Kristine Salma-Ancane

Förderung

  • H2020 Spreading Excellence and Widening Participation
  • Rigas Tehniska Universitate

Zitieren

APA

Sceglovs, A., Siverino, C., Skadins, I., Sceglova, M., Pirsko, V., Moriarty, T. F., Kroica, J., & Salma-Ancane, K. (2025). Injectable ε-Polylysine/Hyaluronic Acid Hydrogels with Resistance-Preventing Antibacterial Activity for Treating Wound Infections. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.5c01252

Vancouver

Sceglovs A, Siverino C, Skadins I, Sceglova M, Pirsko V, Moriarty TF, et al. Injectable ε-Polylysine/Hyaluronic Acid Hydrogels with Resistance-Preventing Antibacterial Activity for Treating Wound Infections. ACS Applied Bio Materials. 2025. doi:10.1021/acsabm.5c01252

BibTeX
@article{Sceglovs2025,
  author = {Sceglovs, Artemijs and Siverino, Claudia and Skadins, Ingus and Sceglova, Marika and Pirsko, Valdis and Moriarty, Thomas Fintan and Kroica, Juta and Salma-Ancane, Kristine},
  title = {Injectable ε-Polylysine/Hyaluronic Acid Hydrogels with Resistance-Preventing Antibacterial Activity for Treating Wound Infections},
  journal = {ACS Applied Bio Materials},
  year = {2025},
  doi = {10.1021/acsabm.5c01252}
}
Kostenlos starten →